Related Experiment Video
Updated: Aug 11, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
[Regulation mechanism of HCV NS5A on p53 protein transactivity]
Guo-zhong Gong1, Yong-fang Jiang, Ying-hua Zhu
1Liver Disease Research Center, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Objective:
To study the inhibition effect of HCV NS5A on p53 protein transactivity and its possible mechanism.
Methods:
Luciferase reporter gene system was used for the study of p53 transactivity on p21 promoter and electrophorectic mobility-shift assay (EMSA) was applied to observe whether HCV NS5A could suppress the binding ability of p53 protein to its specific DNA sequence.
Results:
Endogenous p53 protein could stimulate p21 promoter activity, and the relative luciferase activity increased significantly (3.49 x 10(5) vs 0.60 x 10(5), t = 5.92, P<0.01). Exogenous p53 protein also up-regulated p21 promoter driving luciferase expression, comparing to the control group (0.47 x 10(5)), the relative luciferase activity increased (5.63 x 10(5)) obviously (t = 10.12, P<0.01). HCV NS5A protein inhibited both endogenous and exogenous p53 transactivity on p21 promoter in a dose-dependent manner (F > or = 20.71, P<0.01). In the experiment of EMSA, p53 could bind to its specific DNA sequence, but when co-transfected with HCV NS5A expressing vector, the p53 binding affinity to its DNA decreased.
Conclusion:
HCV NS5A can inhibit p53 protein transactivity on p21 promoter through its inhibiting of p53 binding ability to the specific DNA sequence.
Insights
Hepatitis C virus NS5A protein inhibits p53 transactivity on the p21 promoter. This occurs by reducing p53
Area of Science:
- Molecular Biology
- Virology
- Cancer Research
Background:
- Hepatitis C virus (HCV) is a significant global health concern.
- The p53 tumor suppressor protein plays a critical role in cellular responses to stress.
- Understanding viral protein interactions with host cell machinery is crucial for therapeutic development.
Purpose of the Study:
- To investigate the inhibitory effect of HCV NS5A on p53 protein transactivity.
- To elucidate the underlying mechanism of HCV NS5A-mediated inhibition of p53.
Main Methods:
- Utilized a luciferase reporter gene system to assess p53 transactivity on the p21 promoter.
- Employed electrophoretic mobility-shift assay (EMSA) to evaluate p53 DNA-binding ability.
- Investigated dose-dependent effects of HCV NS5A expression.
Main Results:
- Both endogenous and exogenous p53 proteins significantly activated the p21 promoter.
- HCV NS5A protein demonstrated a dose-dependent inhibition of p53 transactivity.
- EMSA revealed that HCV NS5A suppresses the binding affinity of p53 to its specific DNA sequence.
Conclusions:
- HCV NS5A effectively inhibits p53 protein transactivity on the p21 promoter.
- The mechanism involves the suppression of p53's DNA-binding ability.
- These findings contribute to understanding HCV pathogenesis and potential therapeutic targets.
Related Concept Videos
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

